TIMOTHY MCINERNEY - 05 May 2025 Form 4 Insider Report for Silence Therapeutics plc (SLN)

Role
Director
Signature
/s/ Rhonda Hellums, Attorney-in-Fact
Issuer symbol
SLN
Transactions as of
05 May 2025
Net transactions value
$0
Form type
4
Filing time
20 May 2025, 16:14:11 UTC
Next filing
06 Jan 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
MCINERNEY TIMOTHY Director C/O SILENCE THERAPEUTICS PLC, 72 HAMMERSMITH ROAD, LONDON, UNITED KINGDOM /s/ Rhonda Hellums, Attorney-in-Fact 20 May 2025 0001226020

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SLN Share Option (Right to Buy) Award $0 +48,000 $0.000000 48,000 05 May 2025 Ordinary Shares 48,000 $1.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option shall vest in equal monthly installments over a three-year period measured from one month following May 5, 2025, subject to the Reporting Person's continuous service as of each applicable vesting date.